Prestige Consumer Healthcare Inc. to Present at the 2023 ICR Conference
Prestige Consumer Healthcare Inc. (NYSE:PBH) will participate in the 2023 ICR Conference, hosting a fireside chat on January 10, 2023, at 2:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Prestige Consumer Healthcare Inc. (NYSE:PBH) will participate in the 2023 ICR Conference, hosting a fireside chat on January 10, 2023, at 2:30 p.m. ET. Interested parties can access the live webcast through the company's website under the 'Investors' section. Prestige Consumer Healthcare distributes various well-known consumer healthcare products including Monistat®, Summer’s Eve®, and Dramamine®. The firm's diverse portfolio serves retail markets in the U.S., Canada, Australia, and other international locations.
Details
News Market Reaction – PBH
The recorded move for PBH in the trading session of this news was -0.32%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TARRYTOWN, N.Y., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in the 2023 ICR Conference and is scheduled to host a fireside chat Tuesday, January 10, 2023 at 2:30 p.m. Eastern Time. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
https://ir.prestigebrands.com/events-presentations/events
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.